Suppression of GDNF production by MPSS treatment following spinal cord injury in the rat.

@article{Nakashima2004SuppressionOG,
  title={Suppression of GDNF production by MPSS treatment following spinal cord injury in the rat.},
  author={Shojiro Nakashima and Yukihiro Matsuyama and Yimin Yu and Kazutoshi Kiuchi and Naoki Ishiguro},
  journal={Neuroreport},
  year={2004},
  volume={15 15},
  pages={2337-40}
}
The synthetic glucocorticosteroid methylprednisolone sodium succinate (MPSS) has been clinically used for the treatment of acute spinal cord injury (SCI) to promote the recovery of neurological functions. However, the mechanisms of its beneficial actions are not entirely understood. Experimental evidence suggests that MPSS may contribute to some extent to… CONTINUE READING